AI085596/AI/NIAID NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2009	1
2010	3
2012	5
2013	4
2014	2
2015	1
2017	3
2018	4
2019	2
2020	1
2023	1
2024	0

1

Neutrophil-activating therapy for the treatment of cancer.

Linde IL, Prestwood TR, Qiu J, Pilarowski G, Linde MH, Zhang X, Shen L, Reticker-Flynn NE, Chiu DK, Sheu LY, Van Deursen S, Tolentino LL, Song WC, Engleman EG. Linde IL, et al. Cancer Cell. 2023 Feb 13;41(2):356-372.e10. doi: 10.1016/j.ccell.2023.01.002. Epub 2023 Jan 26. Cancer Cell. 2023. PMID: 36706760 Free PMC article.

2

Properdin in complement activation and tissue injury.

Lesher AM, Nilsson B, Song WC. Lesher AM, et al. Mol Immunol. 2013 Dec 15;56(3):191-8. doi: 10.1016/j.molimm.2013.06.002. Epub 2013 Jun 29. Mol Immunol. 2013. PMID: 23816404 Free PMC article. Review.

3

COVID-19, microangiopathy, hemostatic activation, and complement.

Song WC, FitzGerald GA. Song WC, et al. J Clin Invest. 2020 Aug 3;130(8):3950-3953. doi: 10.1172/JCI140183. J Clin Invest. 2020. PMID: 32459663 Free PMC article. No abstract available.

4

Review: Complement and its regulatory proteins in kidney diseases.

Lesher AM, Song WC. Lesher AM, et al. Nephrology (Carlton). 2010 Oct;15(7):663-75. doi: 10.1111/j.1440-1797.2010.01373.x. Nephrology (Carlton). 2010. PMID: 21040161 Free PMC article. Review.

5

Role and mechanism of action of complement in regulating T cell immunity.

Dunkelberger JR, Song WC. Dunkelberger JR, et al. Mol Immunol. 2010 Aug;47(13):2176-86. doi: 10.1016/j.molimm.2010.05.008. Epub 2010 Jun 18. Mol Immunol. 2010. PMID: 20603023 Free PMC article. Review.

6

Antibody Inhibition of Properdin Prevents Complement-Mediated Intravascular and Extravascular Hemolysis.

Gullipalli D, Zhang F, Sato S, Ueda Y, Kimura Y, Golla M, Miwa T, Wang J, Song WC. Gullipalli D, et al. J Immunol. 2018 Aug 1;201(3):1021-1029. doi: 10.4049/jimmunol.1800384. Epub 2018 Jun 13. J Immunol. 2018. PMID: 29898960 Free PMC article.

7

Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.

Ueda Y, Miwa T, Gullipalli D, Sato S, Ito D, Kim H, Palmer M, Song WC. Ueda Y, et al. J Am Soc Nephrol. 2018 Jul;29(7):1928-1937. doi: 10.1681/ASN.2017121244. Epub 2018 Jun 1. J Am Soc Nephrol. 2018. PMID: 29858280 Free PMC article.

8

Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.

Wang X, Van Lookeren Campagne M, Katschke KJ Jr, Gullipalli D, Miwa T, Ueda Y, Wang Y, Palmer M, Xing G, Song WC. Wang X, et al. J Am Soc Nephrol. 2018 Aug;29(8):2053-2059. doi: 10.1681/ASN.2018030270. Epub 2018 Jun 12. J Am Soc Nephrol. 2018. PMID: 29895552 Free PMC article.

9

Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.

Zhang C, Li Y, Wang C, Wu Y, Cui W, Miwa T, Sato S, Li H, Song WC, Du J. Zhang C, et al. Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1240-8. doi: 10.1161/ATVBAHA.113.303120. Epub 2014 Apr 17. Arterioscler Thromb Vasc Biol. 2014. PMID: 24743429

10

Complement C3a signaling facilitates skeletal muscle regeneration by regulating monocyte function and trafficking.

Zhang C, Wang C, Li Y, Miwa T, Liu C, Cui W, Song WC, Du J. Zhang C, et al. Nat Commun. 2017 Dec 12;8(1):2078. doi: 10.1038/s41467-017-01526-z. Nat Commun. 2017. PMID: 29233958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

25 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year